Cyclandelate
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Cyclandelate" – news · newspapers · books · scholar · JSTOR (October 2021) (Learn how and when to remove this message)
Find sources: "Cyclandelate" – news · newspapers · books · scholar · JSTOR (October 2021) (Learn how and when to remove this message)
Pharmaceutical compound
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.611 Edit this at Wikidata |
Chemical and physical data | |
Formula | C17H24O3 |
Molar mass | 276.376 g·mol−1 |
3D model (JSmol) | |
Melting point | 55 to 56.5 °C (131.0 to 133.7 °F) |
Boiling point | 192 to 194 °C (378 to 381 °F) (14 mmHg) |
| |
| |
(verify) |
Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease.[1] It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.
References
[edit ]- ^ Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.
Stub icon
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.